Company: MVNC
Filing Date: 2025-01-21
Form Type: DEF 14C
Source: 0001683168-25-000446
Chunk: 4

Company: Marvion Inc.
Filing Date: 2025-01-21
Form: DEF 14C
Chunk 4
---
 event an action is approved by written consent, a company must provide notice of
the taking of any corporate action without a meeting to all stockholders who were entitled to vote upon the action but who have not consented
to the action.

As of the Record Date, MVNC had
308,958,835 shares of common stock outstanding and 10,000,000 shares of Series A Preferred Stock issued and outstanding. The
holder of each share of Series A Preferred Stock of MVNC is entitled to vote on all matters submitted to a vote of the shareholders together
with the Common Stock holders with each one share of Series A Preferred Stock having 200 votes. The voting power representing not less
than 1,154,479,418 shares of common stock (expressed to account for the voting power of the Series A Preferred Stock) is required to pass
any stockholder resolutions. Pursuant to Section 78.320 of the NRS, the following stockholders holding an aggregate of 2,018,226,773
shares of common stock, or approximately 87.41% of the outstanding shares of our common stock on the Record Date (expressed to account
for the voting power of the Series A Preferred Stock), delivered an executed written consent dated December 28, 2024, authorizing the
Corporate Actions.

| Name               | Common Shares Beneficially Held* | Percentage of Issued and Outstanding |
| Young Chi Kin Eric |                    2,018,226,773 | 87.41%                               |
| TOTAL              |                    2,018,226,773 | 87.41%                               |

*After accounting for the voting power of the Series A Preferred
Stock.

The Corporate Actions will
not be effective until the date that is twenty (20) days after the mailing of this Information Statement, which is expected to be February
10, 2025 (the “Effective Date”). No further action on the part of stockholders is required to authorize or effect the Corporate
Actions.

<div align='center'>NO APPRAISAL RIGHTS</div>

Under the NRS, stockholders are
not entitled to appraisal rights with respect to the Corporate Actions, and we will not provide our stockholders with such rights.

<div align='center'>INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON</div>

Except in their capacity as stockholders,
none of our officers, directors or any of their respective affiliates has any interest in the Corporate Actions